Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
Journal of the Royal Society of Medicine
|
April 7, 2022
Machine learning-driven critical care decision making
James T Coates, Christiaan de Koning
The British Journal of Radiology
|
February 14, 2018
Targeting tumour hypoxia: shifting focus from oxygen supply to demand
James T Coates, Michael Skwarski, Geoff S Higgins
Medical Physics
|
May 18, 2020
Genomics models in radiotherapy: From mechanistic to machine learning
John Kang, James T Coates, Robert L Strawderman, et al.
Cancer Discovery
|
August 18, 2021
Parallel Genomic Alterations of Antigen and Payload Targets Mediate Polyclonal Acquired Clinical Resistance to Sacituzumab Govitecan in Triple-Negative Breast Cancer
James T Coates, Sheng Sun, Ignaty Leshchiner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 6, 2024
Antibody-Drug Conjugate Sacituzumab Govitecan Enables a Sequential TOP1/PARP Inhibitor Therapy Strategy in Patients with Breast Cancer
Aditya Bardia, Sheng Sun, Nayana Thimmiah, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
Journal of the Royal Society of Medicine
|
April 7, 2022
Machine learning-driven critical care decision making
James T Coates, Christiaan de Koning
The British Journal of Radiology
|
February 14, 2018
Targeting tumour hypoxia: shifting focus from oxygen supply to demand
James T Coates, Michael Skwarski, Geoff S Higgins
Medical Physics
|
May 18, 2020
Genomics models in radiotherapy: From mechanistic to machine learning
John Kang, James T Coates, Robert L Strawderman, et al.
Cancer Discovery
|
August 18, 2021
Parallel Genomic Alterations of Antigen and Payload Targets Mediate Polyclonal Acquired Clinical Resistance to Sacituzumab Govitecan in Triple-Negative Breast Cancer
James T Coates, Sheng Sun, Ignaty Leshchiner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 6, 2024
Antibody-Drug Conjugate Sacituzumab Govitecan Enables a Sequential TOP1/PARP Inhibitor Therapy Strategy in Patients with Breast Cancer
Aditya Bardia, Sheng Sun, Nayana Thimmiah, et al.
Page
of 1